1)- Yuanteng Jeff Li, Victor G Prieto, Jean Tayar. Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL.RMD open. 2023, 9 (4):
2)- Pierre-Antoine Juge, Lidwine Wemeau, Sebastien Ottaviani, Guillaume Desjeux, Joe Zhuo, Virginie Vannier-Moreau, René-Marc Flipo, Bruno Crestani, Philippe Dieudé. Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database.RMD open. 2023, 9 (4):
3)- Reinder Raadsen, Romy Hansildaar, Lianne C Pouw, Femke Hooijberg, Laura Boekel, Gerrit Jan Wolbink, Arno W R van Kuijk, Michael T Nurmohamed. Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated.RMD open. 2023, 9 (4):
4)- Michelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, Nicole V Borggreven, Tom Wj Huizinga, Annette Hm van der Helm-van Mil, René Em Toes, Diane van der Woude, Leendert A Trouw. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.RMD open. 2023, 9 (4):
5)- Filippo Fagni, Melek Yalcin Mutlu, Selahattin Alp Temiz, Ioanna Minopoulou, Manuel Krieter, Georg Schett, Arnd Kleyer, David Simon, Axel J Hueber. Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis.RMD open. 2023, 9 (4):
6)- Antonio Vitale, Valeria Caggiano, Giuseppe Lopalco, Henrique A Mayrink Giardini, Francesco Ciccia, Ibrahim A Almaghlouth, Piero Ruscitti, Petros P Sfikakis, Abdurrahman Tufan, Lorenzo Dagna, Roberto Giacomelli, Andrea Hinojosa-Azaola, Gafaar Ragab, Haner Direskeneli, Lampros Fotis, Jurgen Sota, Florenzo Iannone, Maria Morrone, Isabele Parente de Brito Antonelli, Marilia Ambiel Dagostin, Daniela Iacono, Martina Patrone, Kazi Asfina, Fehaid Alanazi, Ilenia Di Cola, Carla Gaggiano, Maria G Tektonid. Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry.RMD open. 2023, 9 (4):
7)- Yanqiu Zhu, Jiatian Li, Yuqing Zhang, Weiya Zhang, Michael Doherty, Zidan Yang, Yang Cui, Chao Zeng, Guanghua Lei, Tuo Yang, Jie Wei. Association between hyperuricaemia and hand osteoarthritis: data from the Xiangya Osteoarthritis Study.RMD open. 2023, 9 (4):
8)- Xin-Yu Fang, Jie Zhang, Ting-Ting Qian, Peng Gao, Qing Wu, Quan Fang, Su-Su Ke, Rong-Gui Huang, Heng-Chuan Zhang, Ni-Ni Qiao, Yin-Guang Fan, Dong-Qing Ye. Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank.RMD open. 2023, 9 (4):
9)- Martin Rudwaleit, Michael F Mørup, Brittany Humphries, Noor-E Zannat, Damon Willems, Vanessa Taieb, Annelies Boonen. Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis.RMD open. 2023, 9 (4):
10)- Alexandra Ladouceur, Thomas Barnetche, Gael Mouterde, Alice Tison, Samuel Bitoun, Sorilla Prey, Caroline Dutriaux, Emilie Gerard, Anne Pham-Ledard, Marie Beylot-Barry, Maeva Zysman, Rémi Veillon, Charlotte Domblides, Amaury Daste, Marine Gross-Goupil, Baptiste Sionneau, Felix Lefort, Mathieu Larroquette, Christophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke, Marie Kostine. Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.RMD open. 2023, 9 (4):
11)- Emilie Rosenfeldt Christensen, Anne Clausen, Tanja Gram Petersen, Michael Kriegbaum Skjødt, Bo Abrahamsen, Sören Möller, Katrine Hass Rubin. Excess mortality following a first and subsequent osteoporotic fracture: a Danish nationwide register-based cohort study on the mediating effects of comorbidities.RMD open. 2023, 9 (4):
13)- Mathias Schneeweiss-Gleixner, Caroline Hillebrand, Stephanie Jaksits, Jonathan Fries, Michael Zauner, Gottfried Heinz, Gürkan Sengölge, Thomas Staudinger, Christian Zauner, Daniel Aletaha, Klaus P Machold, Peter Schellongowski, Manuel Bécède. Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit.RMD open. 2023, 9 (4):
14)- Adrian Ciurea, Andrea Götschi, René Bräm, Kristina Bürki, Pascale Exer, Michael Andor, Michael J Nissen, Burkhard Möller, Thomas Hügle, Andrea Rubbert-Roth, Diego Kyburz, Oliver Distler, Almut Scherer, Raphael Micheroli. Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.RMD open. 2023, 9 (4):
15)- George C Drosos, George Konstantonis, Petros P Sfikakis, Maria G Tektonidou. Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.RMD open. 2023, 9 (4):
18)- Olivier Fakih, Maxime Desmarets, Bérenger Martin, Clement Prati, Elisabeth Monnet, Frank Verhoeven, Daniel Wendling. Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study.RMD open. 2023, 9 (4):
20)- Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Johan Askling. Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis.RMD open. 2023, 9 (4):
21)- Xiuyuan Wang, Mengyang Liu, Tianbao Ye, Junxia Huang, Xinzhi Xu, Ming Li, Xuefeng Zhao, Hongliang Lu, Ji Yang. A stretchable hardness sensor for the assessment of skin disease in systemic sclerosis.RMD open. 2023, 9 (4):
22)- Muriel Elhai, Diego Benavent, Krystel Aouad, Paul Studenic, Heidi Bertheussen, Jette Primdahl, Codruta Zabalan, Maarten de Wit, Laure Gossec. Involving patients as research partners in research in rheumatology: a literature review in 2023.RMD open. 2023, 9 (4):
23)- Duncan Porter, Sahil Jain, Evelyn Qian, Fraser R Morton, Iain B McInnes. Time-varying risks of infection in patients as they proceed through the phases of 'pre-RA': results from the Scottish Early RA inception cohort.RMD open. 2023, 9 (4):
24)- Piero Ruscitti, Francesco Masedu, Antonio Vitale, Ilenia Di Cola, Valeria Caggiano, Claudia Di Muzio, Paola Cipriani, Marco Valenti, Onorina Berardicurti, Luca Navarini, Daniela Iacono, Ilenia Pantano, Daniele Mauro, Francesco Ciccia, Silvia Rossi, Ludovico De Stefano, Sara Monti, Serena Bugatti, Carlomaurizio Montecucco, Francesco Caso, Luisa Costa, Marcella Prete, Federico Perosa, Annamaria Iagnocco, Fabiola Atzeni, Giuliana Guggino, Henrique Giardini, Isabele Parente de Brito Antonelli, Ibrah. Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.RMD open. 2023, 9 (4):
25)- Jiwei Wang, Peiqi Hao, Xianrun Sun, Richard Ward, Tao Tang, Xi Chen, Yihong Liu, Guancong Luo, Yang Yang, Cheng Xiang, Su An, Tian-Rui Xu. New animal model of chronic gout reproduces pathological features of the disease in humans.RMD open. 2023, 9 (4):
26)- . Correction: Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.RMD open. 2023, 9 (4):
27)- Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling. Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden.RMD open. 2023, 9 (4):
28)- Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir. Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study.RMD open. 2023, 9 (4):
29)- Junke Miao, Jingyuan Zhang, Xin Huang, Na Wu, Di Wu, Min Shen. -associated autoinflammatory disease in Chinese adult patients: a single-centre study.RMD open. 2023, 9 (4):
30)- Imke Redeker, Robert Landewé, Désirée van der Heijde, Sofia Ramiro, Annelies Boonen, Maxime Dougados, Jürgen Braun, Uta Kiltz. Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort.RMD open. 2023, 9 (4):
31)- Catherine D Hughes, Sarah E Ryan, Kathryn J A Steel, Michelle D van den Beukel, L A Trouw, Karin A J van Schie, René E M Toes, Bina Menon, Bruce W Kirkham, Leonie S Taams. Type 17-specific immune pathways are active in early spondyloarthritis.RMD open. 2023, 9 (4):
32)- . Correction: The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.RMD open. 2023, 9 (4):
33)- Laura Pina Vegas, Laetitia Penso, Emilie Sbidian, Pascal Claudepierre. Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS).RMD open. 2023, 9 (4):
34)- Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, . Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial.RMD open. 2023, 9 (4):
36)- Nathan J Dean, Ian J Clifton, Rashad Salman, Charles Bridgewood, Jacquie Nam, Tom Macleod, Dennis G McGonagle. Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis.RMD open. 2023, 9 (4):
37)- . Correction: Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus.RMD open. 2023, 9 (4):
38)- Marie-Therese Holzer, Nikolas Ruffer, Tobias B Huber, Ina Kötter, Lennard Ostendorf, Martin Krusche. Daratumumab for autoimmune diseases: a systematic review.RMD open. 2023, 9 (4):
40)- Fleur Baumann Benvenuti, Jean Dudler. Long-lasting improvement of refractory antisynthetase syndrome with tocilizumab: a report of two cases.RMD open. 2023, 9 (4):
42)- Faranaz Atschekzei, Mykola Fedchenko, Abdulwahab Elsayed, Natalia Dubrowinskaja, Theresa Graalmann, Felix C Ringshausen, Torsten Witte, Georgios Sogkas. Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in .RMD open. 2023, 9 (4):
44)- Ariane Do, Lorenzo Garzelli, Robert Garnier, Charles Court, Jérémie Sellam, Anne Miquel, Francis Berenbaum. Inflammatory low back pain with radiculopathy revealing epidural disintegration of a bullet complicated by lead poisoning.RMD open. 2023, 9 (4):
45)- Vasco C Romão, Pedro Ávila-Ribeiro, Maria João Gonçalves, Rita Cruz-Machado, André Bento Guerreiro, Vítor Teixeira, Ana Valido, Joana Silva-Dinis, Elsa Vieira-Sousa, Maria João Saavedra, Ema Sacadura-Leite, Rui Tato Marinho, Joao Fonseca. Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics.RMD open. 2023, 9 (4):
46)- Bayram Farisogullari, Eduardo José Ferreira Santos, Emma Dures, Rinie Geenen, Pedro M Machado, , . Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.RMD open. 2023, 9 (4):
47)- Philip Hamann, Johannes Knitza, Sebastian Kuhn, Rachel Knevel. Recommendation to implementation of remote patient monitoring in rheumatology: lessons learned and barriers to take.RMD open. 2023, 9 (4):
48)- Lou Kawka, Juan-Camilo Sarmiento-Monroy, Philippe Mertz, Luc Pijnenburg, Marina Rinagel, Manuel Francisco Ugarte-Gil, Sophie Geneton, Julien Blaess, Matteo Piga, Laurent Arnaud. Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study.RMD open. 2023, 9 (4):
49)- Fenghao Zhang, Yiran Cui, Xiao Gao. Time trends in the burden of autoimmune diseases across the BRICS: an age-period-cohort analysis for the GBD 2019.RMD open. 2023, 9 (4):
50)- Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore K Kvien, Espen A Haavardsholm, Hilde Berner Hammer. Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study.RMD open. 2023, 9 (4):